STRAGEN is an independent Swiss company founded in 1990, specialized in the development and commercialization of niche Generic and Generic+ pharmaceuticals, innovative consumer health products, and in the early-stage development of new drugs. STRAGEN also offers a range of specifically tailored consulting services for pharmacovigilance and clinical development strategies.
EstroFree-100®, SniZtop® and Leviker®, the INNOV range of STRAGEN Consumer Health, …read more
SniZtop®, the natural histamine blocker for fast allergy relief, is now available in more than 30 countries worldwide…read more
After several years of development, the Urapidil Oral dossier has been approved in Germany, Slovakia, …read more